1.
Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet
by Bakker, Marije F
Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.830-835
2.
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)
by H. Hohnloser, Stefan
The American heart journal, 2006, Vol.152 (3), p.442-447
3.
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
by Di Angelantonio, Emanuele
The Lancet (British edition), 2016, Vol.388 (10046), p.776-786
4.
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
by Valgimigli, Marco, Dr
The Lancet (British edition), 2015, Vol.385 (9986), p.2465-2476
5.
Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3...
by Baharoglu, M Irem, MD
The Lancet (British edition), 2016, Vol.387 (10038), p.2605-2613
6.
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II...
by Steinberg, Benjamin A
The American heart journal, 2017-12, Vol.194, p.132-140
7.
Drinking of maté and the risk of cancers of the upper aerodigestive tract in Latin America: a case—control study
by Szymańska, K
Cancer causes & control, 2010-11-01, Vol.21 (11), p.1799-1806
8.
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
by Lublin, Fred, Prof
The Lancet (British edition), 2016-03-12, Vol.387 (10023), p.1075-1084
9.
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
by Cervera, R
Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1011-1018
10.
The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: a randomised controlled trial
by Patel, Vikram, Prof
The Lancet (British edition), 2016, Vol.389 (10065), p.176-185
11.
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
by Clive, Amelia O
Thorax, 2014-12, Vol.69 (12), p.1098-1104
12.
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients
by Elkiran, Emin Tamer
Medical oncology (Northwood, London, England), 2012-06-22, Vol.29 (5), p.3147-3154
13.
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
by Khanna, Dinesh, Prof
The Lancet (British edition), 2016-06-25, Vol.387 (10038), p.2630-2640
14.
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised,...
by de Boer, Stephanie M
The lancet oncology, 2018-03, Vol.19 (3), p.295-309
15.
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
by Slotman, Ben J, MD
The Lancet (British edition), 2015, Vol.385 (9962), p.36-42
16.
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, pla...
by Nguyen, Quan Dong, Prof Dr
The Lancet (British edition), 2016, Vol.388 (10050), p.1183-1192
17.
Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe
by Bots, M L
Journal of epidemiology and community health (1979), 2002-02, Vol.56 (suppl 1), p.i19-i24
18.
Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis
by Klompmaker, Sjors
Annals of surgical oncology, 2019-03-15, Vol.26 (3), p.772-781
19.
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
by Palfi, Stéphane, Prof
The Lancet (British edition), 2014, Vol.383 (9923), p.1138-1146
20.
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled...
by Costa, Francesco, MD
The Lancet (British edition), 2017, Vol.389 (10073), p.1025-1034
